Molecular cloning studies have revealed numerous mammalian neuronal GABA-A receptor subunits and have helped explain the diversity of receptors found in vitro. Certain subunit combinations or mutations result in different GABA affinity, efficacy or pharmacology of resultant receptors; however little is known about what microscopic mechanisms underlie these observations or how these receptors function under synaptic-like conditions of transient GABA exposure. The hypothesis is: Receptor composition and specific molecular determinants alter events or processes involved in microscopic kinetics of GABA binding, channel gating and receptor deactivation and allosteric modulation that are relevant to the synapse. In an effort to study the role of subunit composition and molecular determinants for GABA receptor function, three specific aims are proposed: #1) Determine functional consequences of subunit composition on affinity, gating and pharmacological modulation of expressed receptors; #2) Evaluate specific amino acids involved in binding, gating and modulation of expressed GABA receptors; and #3) Correlate GABA-A receptor subunit mRNA and with electrophysiological properties of receptors in individual neurons. Ultrafast ligand exchange (100 su) and electrophysiological techniques will be used to study excised patches of defined subunit combinations expressed in HEK 293 cells. The investigators will directly resolve processes involved in receptor activation and gating and also study receptor function and pharmacology that better recapitulates agonist activity in the synapse. To further correlate information on genetic expression with receptor function, single cell RT-PCR techniques will qualitatively determine mRNA present in living neurons and kinetic fingerprints will be obtained with neuronal receptor system responses evoked by <1 ms GABA applications. This project will improve our understanding of the molecular correlates of GABA receptor structure and function which can result in better therapeutic intervention in epilepsy, anxiety and anesthesia.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
2R01NS031519-05
Application #
2410357
Study Section
Neurological Sciences Subcommittee 1 (NLS)
Program Officer
Baughman, Robert W
Project Start
1993-07-01
Project End
2000-05-31
Budget Start
1997-09-01
Budget End
1998-05-31
Support Year
5
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of Utah
Department
Biochemistry
Type
Schools of Medicine
DUNS #
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Bamber, Bruce A; Twyman, Roy E; Jorgensen, Erik M (2003) Pharmacological characterization of the homomeric and heteromeric UNC-49 GABA receptors in C. elegans. Br J Pharmacol 138:883-93
Twyman, R E; Rogers, S W; Gahring, L C et al. (1999) Antibodies to glutamate receptors: a role in excitatory dysregulation of the central nervous system? Adv Neurol 79:535-41
Bamber, B A; Beg, A A; Twyman, R E et al. (1999) The Caenorhabditis elegans unc-49 locus encodes multiple subunits of a heteromultimeric GABA receptor. J Neurosci 19:5348-59
McClellan, A M; Twyman, R E (1999) Receptor system response kinetics reveal functional subtypes of native murine and recombinant human GABAA receptors. J Physiol 515 ( Pt 3):711-27
Donevan, S D; Beg, A; Gunther, J M et al. (1998) The methylglutamate, SYM 2081, is a potent and highly selective agonist at kainate receptors. J Pharmacol Exp Ther 285:539-45
Lavoie, A M; Tingey, J J; Harrison, N L et al. (1997) Activation and deactivation rates of recombinant GABA(A) receptor channels are dependent on alpha-subunit isoform. Biophys J 73:2518-26
Gahring, L C; Rogers, S W; Twyman, R E (1997) Autoantibodies to glutamate receptor subunit GluR2 in nonfamilial olivopontocerebellar degeneration. Neurology 48:494-500
Lavoie, A M; Twyman, R E (1996) Direct evidence for diazepam modulation of GABAA receptor microscopic affinity. Neuropharmacology 35:1383-92
Twyman, R E; Gahring, L C; Spiess, J et al. (1995) Glutamate receptor antibodies activate a subset of receptors and reveal an agonist binding site. Neuron 14:755-62
Skeen, G A; White, H S; Twyman, R E (1994) The dihydropyridine nitrendipine reduces N-methyl-D-aspartate (NMDA)-evoked currents of rodent cortical neurons through a direct interaction with the NMDA receptor-associated ion channel. J Pharmacol Exp Ther 271:30-8